Annovis Bio, Inc. Common Stock (NY:ANVS)

1.180 +0.010 (+0.85%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Annovis Bio, Inc. Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

18 19 Next >

Annovis Bio to Participate in the Biotech Showcase and H.C. Wainwright Bioconnect Virtual Conferences

January 03, 2022

Berwyn, Pennsylvania--(Newsfile Corp. - January 3, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug...

Via Newsfile

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 27, 2021

Gainers OptiNose (NASDAQ:OPTN) shares mov...

Via Benzinga

Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials ↗

December 27, 2021

Image provided by Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders

December 20, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - December 20, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics

December 14, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - December 14, 2021) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug...

Via Newsfile

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 03, 2021

Gainers Lixte Biotech Holdings (NASDAQ:LIXT

Via Benzinga

Annovis Bio Presented At The 14th Clinical Trials on Alzheimer's Disease Conference

November 12, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - November 12, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗

November 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...

Via Benzinga

Annovis Bio Presents Poster on Mechanism of Action at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference

November 09, 2021

Berwyn, Pennsylvania--(Newsfile Corp. - November 9, 2021) - Annovis Bio, Inc. (NYSE American: ANVS) ("Annovis" or the "Company"), a clinical-stage...

Via Newsfile

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

SHAREHOLDER ALERT: Robbins LLP Investigates Annovis Bio, Inc. (ANVS) for Misleading Shareholders

November 03, 2021

From Robbins LLP

Via Business Wire

92 Biggest Movers From Friday ↗

November 08, 2021

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...

Via Benzinga

Annovis Bio to Present at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference

November 02, 2021

Dr. Maria Maccecchini will present additional Phase 2 data on November 12, 10:25 a.m. ESTA poster highlighting the mechanism of...

Via Newsfile

Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market ↗

October 21, 2021

Cortexyme is testing a twice-day pill to treat Alzheimer's disease.

Via Investor's Business Daily

ANNOVIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Annovis Bio, Inc. and Encourages Investors to Contact the Firm

October 15, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

44 Biggest Movers From Yesterday ↗

October 15, 2021

Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after...

Via Benzinga

MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 16, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 14, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

3 Stocks Insiders Are Buying ↗

October 14, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

CLASS ACTION UPDATE for ANVS, HNST and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

October 13, 2021

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Initial Public Offering Lawsuit

LAWSUITS FILED AGAINST ANVS, EAR and HYZN - Jakubowitz Law Pursues Shareholders Claims

October 13, 2021

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of LIVE, ANVS and SAVA

October 12, 2021

NEW YORK, NY / ACCESSWIRE / October 12, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

From The Gross Law Firm

Via AccessWire

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPLT, ANVS and WDH

October 12, 2021

From The Gross Law Firm

Via AccessWire

Topics Initial Public Offering Lawsuit

MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

October 12, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

MONDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Annovis Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ANVS

October 12, 2021

SAN DIEGO, CA / ACCESSWIRE / October 12, 2021 / Robbins Geller Rudman & Dowd LLP announces that purchasers of Annovis Bio, Inc. (NYSE:ANVS) securities between May 21, 2021 and July 28, 2021, both dates...

From Robbins Geller Rudman & Dowd LLP

Via AccessWire

Topics Lawsuit

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ANVS, VIEW and SESN

October 12, 2021

NEW YORK, NY / ACCESSWIRE / October 12, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud

LAWSUITS FILED AGAINST ANVS, VIEW and WDH - Jakubowitz Law Pursues Shareholders Claims

October 12, 2021

NEW YORK, NY / ACCESSWIRE / October 12, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Initial Public Offering Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SLQT, ANVS and ATIP

October 12, 2021

From The Gross Law Firm

Via AccessWire

Topics Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of YALA, LIVE and ANVS

October 11, 2021

NEW YORK, NY / ACCESSWIRE / October 11, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

From The Gross Law Firm

Via AccessWire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.